Floranne C Ernste1, Christopher Chong2, Cynthia S Crowson3, Tanaz A Kermani4, Orla Ni Mhuircheartaigh5, Helene Alexanderson6. 1. F.C. Ernste, MD, Division of Rheumatology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA; ernste.floranne@mayo.edu. 2. C. Chong, MD, Arthritis Associates and Osteoporosis Center of Colorado Springs, Colorado Springs, Colorado, USA. 3. C.S. Crowson, PhD, Department of Health Science Research, Division of Biostatistics, Mayo Clinic, Rochester, Minnesota, USA. 4. T.A. Kermani, MD, University of California at Los Angeles, California, USA. 5. O. Ni Mhuircheartaigh, MBBCh, Division of Rheumatology, Department of Medicine, Beacon Hospital, Dublin, Ireland. 6. H. Alexanderson, PhD, Department of Neurobiology, Care Science and Society, Division of Physiotherapy, and Department of Medicine, Division of Rheumatology Karolinska Institutet, and Function Area Occupational Therapy and Physical Therapy, Karolinska University Hospital, Solna, Stockholm, Sweden.
Abstract
OBJECTIVE: Patients with dermatomyositis (DM) and polymyositis (PM) have reduced muscle endurance.The aim of this study was to streamline the Functional Index-2 (FI-2) by developing the Functional Index-3 (FI-3) and to evaluate its measurement properties, content and construct validity, and intra- and interrater reliability. METHODS: A dataset of the previously performed and validated FI-2 (n = 63) was analyzed for internal redundancy, floor, and ceiling effects. The content of the FI-2 was revised into the FI-3. Construct validity and intrarater reliability of FI-3 were tested on 43 DM and PM patients at 2 rheumatology centers. Interrater reliability was tested in 25 patients. The construct validity was compared with the Myositis Activities Profile (MAP), Health Assessment Questionnaire (HAQ), and Borg CR-10 using Spearman correlation coefficient. RESULTS: Spearman correlation coefficients of 63 patients performing FI-3 revealed moderate to high correlations between shoulder flexion and hip flexion tasks and similar correlations with MAP and HAQ scores; there were lower correlations for neck flexion task. All FI-3 tasks had very low to moderate correlations with the Borg scale. Intraclass correlation coefficients (ICC) of FI-3 tasks for intrarater reliability (n = 25) were moderate to good (0.88-0.98). ICC of FI-3 tasks for interrater reliability (n = 17) were fair to good (range 0.83-0.96). CONCLUSION: The FI-3 is an efficient and valid method for clinically assessing muscle endurance in DM and PM patients. FI-3 construct validity is supported by the significant correlations between functional tasks and the MAP, HAQ, and Borg CR-10 scores.
OBJECTIVE: Patients with dermatomyositis (DM) and polymyositis (PM) have reduced muscle endurance.The aim of this study was to streamline the Functional Index-2 (FI-2) by developing the Functional Index-3 (FI-3) and to evaluate its measurement properties, content and construct validity, and intra- and interrater reliability. METHODS: A dataset of the previously performed and validated FI-2 (n = 63) was analyzed for internal redundancy, floor, and ceiling effects. The content of the FI-2 was revised into the FI-3. Construct validity and intrarater reliability of FI-3 were tested on 43 DM and PM patients at 2 rheumatology centers. Interrater reliability was tested in 25 patients. The construct validity was compared with the Myositis Activities Profile (MAP), Health Assessment Questionnaire (HAQ), and Borg CR-10 using Spearman correlation coefficient. RESULTS: Spearman correlation coefficients of 63 patients performing FI-3 revealed moderate to high correlations between shoulder flexion and hip flexion tasks and similar correlations with MAP and HAQ scores; there were lower correlations for neck flexion task. All FI-3 tasks had very low to moderate correlations with the Borg scale. Intraclass correlation coefficients (ICC) of FI-3 tasks for intrarater reliability (n = 25) were moderate to good (0.88-0.98). ICC of FI-3 tasks for interrater reliability (n = 17) were fair to good (range 0.83-0.96). CONCLUSION: The FI-3 is an efficient and valid method for clinically assessing muscle endurance in DM and PM patients. FI-3 construct validity is supported by the significant correlations between functional tasks and the MAP, HAQ, and Borg CR-10 scores.
Authors: G F Wiesinger; M Quittan; M Nuhr; B Volc-Platzer; G Ebenbichler; M Zehetgruber; W Graninger Journal: Arch Phys Med Rehabil Date: 2000-01 Impact factor: 3.966
Authors: Lisa G Rider; Edward H Giannini; Michael Harris-Love; Galen Joe; David Isenberg; Clarissa Pilkington; Peter A Lachenbruch; Frederick W Miller Journal: J Rheumatol Date: 2003-03 Impact factor: 4.666
Authors: M O Harris-Love; J A Shrader; D Koziol; N Pahlajani; M Jain; M Smith; H L Cintas; C L McGarvey; L James-Newton; A Pokrovnichka; B Moini; I Cabalar; D J Lovell; R Wesley; P H Plotz; F W Miller; J E Hicks; L G Rider Journal: Rheumatology (Oxford) Date: 2008-12-11 Impact factor: 7.580
Authors: I Loell; S B Helmers; M Dastmalchi; H Alexanderson; L A Munters; I Nennesmo; E Lindroos; K Borg; I E Lundberg; M Esbjörnsson Journal: Clin Physiol Funct Imaging Date: 2010-10-01 Impact factor: 2.273
Authors: Helene Alexanderson; Maryam Dastmalchi; Mona Esbjörnsson-Liljedahl; Christina H Opava; Ingrid E Lundberg Journal: Arthritis Rheum Date: 2007-06-15
Authors: Helene Alexanderson; Lisbet Broman; Anna Tollbäck; Annika Josefson; Ingrid E Lundberg; Christina H Stenström Journal: Arthritis Rheum Date: 2006-02-15
Authors: Michael O Harris-Love; Galen Joe; Todd E Davenport; Deloris Koziol; Kristen Abbett Rose; Joseph A Shrader; Olavo M Vasconcelos; Beverly McElroy; Marinos C Dalakas Journal: Arthritis Care Res (Hoboken) Date: 2015-04 Impact factor: 4.794
Authors: Helene Alexanderson; Malin Regardt; Christina Ottosson; Li Alemo Munters; Maryam Dastmalchi; Lara Dani; Ingrid E Lundberg Journal: J Rheumatol Date: 2018-02-01 Impact factor: 4.666
Authors: Henrik Pettersson; Helene Alexanderson; Janet L Poole; Janos Varga; Malin Regardt; Anne-Marie Russell; Yasser Salam; Kelly Jensen; Jennifer Mansour; Tracy Frech; Carol Feghali-Bostwick; Cecília Varjú; Nancy Baldwin; Matty Heenan; Kim Fligelstone; Monica Holmner; Matthew R Lammi; Mary Beth Scholand; Lee Shapiro; Elizabeth R Volkmann; Lesley Ann Saketkoo Journal: Best Pract Res Clin Rheumatol Date: 2021-07-01 Impact factor: 4.991